000 01151 a2200325 4500
005 20250515104830.0
264 0 _c20080321
008 200803s 0 0 eng d
022 _a1567-2050
024 7 _a10.2174/156720507783018343
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWindisch, Manfred
245 0 0 _aIs alpha-synuclein pathology a target for treatment of neurodegenerative disorders?
_h[electronic resource]
260 _bCurrent Alzheimer research
_cDec 2007
300 _a556-61 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aDisease Models, Animal
650 0 4 _aHumans
650 0 4 _aNeurodegenerative Diseases
_xdrug therapy
650 0 4 _aNeuroprotective Agents
_xchemistry
650 0 4 _aPeptide Library
650 0 4 _aPeptides
_xtherapeutic use
650 0 4 _aalpha-Synuclein
_xchemistry
700 1 _aWolf, Hans-Jörg
700 1 _aHutter-Paier, Birgit
700 1 _aWronski, Robert
773 0 _tCurrent Alzheimer research
_gvol. 4
_gno. 5
_gp. 556-61
856 4 0 _uhttps://doi.org/10.2174/156720507783018343
_zAvailable from publisher's website
999 _c17727758
_d17727758